{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "toremifene citrate",
      "indication": "1 INDICATIONS AND USAGE Toremifene citrate tablets are estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. Toremifene citrate tablets are estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.",
      "manufacturer": "MSN LABORATORIES PRIVATE LIMITED",
      "splSetId": "0b3ebaa6-9cbe-405e-8f14-14ce8dcd2a68"
    },
    {
      "brand": "Fareston",
      "indication": "1 INDICATIONS AND USAGE FARESTON\u00ae is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. FARESTON\u00ae is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. ( 1 )",
      "manufacturer": "KYOWA KIRIN, INC,",
      "splSetId": "2cab8dd1-3a10-48e6-86ce-0e5275ed49e5"
    },
    {
      "brand": "Toremifene Citrate",
      "indication": "1 INDICATIONS AND USAGE Toremifene citrate tablets are an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. Toremifene citrate tablets are an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.(1)",
      "manufacturer": "Rising Pharmaceuticals, Inc.",
      "splSetId": "dbde10d5-c689-428f-841d-b34aa5addf2d"
    },
    {
      "brand": "toremifene citrate",
      "indication": "1 INDICATIONS AND USAGE Toremifene citrate tablets are estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. Toremifene citrate tablets are estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.",
      "manufacturer": "Novadoz Pharmaceuticals LLC",
      "splSetId": "e897546b-4136-4cb5-a262-d94cf3fa3298"
    }
  ],
  "id": "Toremifene_Citrate",
  "nciThesaurus": {
    "casRegistry": "89778-27-8",
    "chebiId": "",
    "chemicalFormula": "C26H28ClNO.C6H8O7",
    "definition": "The citrate salt of a nonsteroidal triphenylethylene antiestrogen.  Chemically related to tamoxifen, toremifene is a selective estrogen receptor modulator (SERM).  This agent binds competitively to estrogen receptors, thereby interfering with estrogen activity.  Toremifene also has intrinsic estrogenic properties, which is manifested depending on the tissue or species.",
    "fdaUniiCode": "2498Y783QT",
    "identifier": "C1756",
    "preferredName": "Toremifene Citrate",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1821"
    ],
    "synonyms": [
      "(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)",
      "2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)- N,N-dimethylethylamine citrate (1:1)",
      "Acapodene",
      "FC-1157a",
      "Fareston",
      "GTx-006",
      "TOREMIFENE CITRATE",
      "Toremifene Citrate",
      "Toremifene citrate"
    ]
  }
}